Skip to main content
. 2017 Oct 26;110(4):426–429. doi: 10.1093/jnci/djx206

Table 1.

Characteristics of pregnancies among patients in the pregnant cohort (n = 333)

Characteristics All patients(n = 333) No. (%) ER-positive patients (n = 194) No. (%) ER-negative patients (n = 139) No. (%) P*
Pregnancy outcome
 Completed pregnancy 188 (56.5) 110 (56.7) 78 (56.1) .69
 Abortion 135 (40.5) 76 (39.2) 59 (42.5)
  Induced abortion 91 (67.4) 53 (69.7) 38 (64.4)
  Spontaneous abortion 22 (16.3) 12 (15.8) 10 (17.0)
  Unknown 22 (16.3) 11 (14.5) 11 (18.6)
 Unknown 10 (3.0) 8 (4.1) 2 (1.4)
Pregnancy interval
 <2 y from diagnosis 140 (42.0) 73 (37.6) 67 (48.2) .06
 ≥2 y from diagnosis 193 (58.0) 121 (62.4) 72 (51.8)
 2–5 y 139 (72.0) 77 (63.6) 62 (86.1)
 >5 y 54 (28.0) 44 (36.4) 10 (13.9)
Breastfeeding status§
 Yes 25 (13.3) 21 (19.1) 4 (5.1) .05
 No 39 (20.7) 23 (20.9) 16 (20.5)
 Unknown 124 (66.0) 66 (60.0) 58 (74.4)
*

Chi-square test or Fisher’s exact test with two-sided P values for the comparison between ER-positive and ER-negative patients calculated by excluding unknown data. ER = estrogen receptor.

Percentages calculated on the total number of patients with abortion (135 in all patients, 76 in women with ER-positive breast cancer, and 59 in those with ER-negative disease).

Percentages calculated on the total number of patients who became pregnant two or more years from diagnosis (193 in all patients, 121 in women with ER-positive breast cancer, and 72 in those with ER-negative disease).

§

Percentages calculated on the total number of patients with completed pregnancy (188 in all patients, 110 in women with ER-positive breast cancer, and 78 in those with ER-negative disease).